Should all preterm babies get extra nutrients? new study tests routine fortification
NCT ID NCT04284280
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 170 extremely preterm infants (born at or before 27 weeks) to see if adding a human milk fortifier to all feedings early on helps them grow better and reduces a dangerous gut condition called necrotizing enterocolitis. One group received the fortifier as soon as they reached full feeds, while the other group got it only if their weight gain was slow. The researchers tracked growth in the hospital and developmental outcomes at two years of age.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Donor Human Milk Fortifier
What this could lead to
If successful, this could show that routine fortification of human milk improves growth and reduces serious gut complications in extremely preterm infants.
What could go wrong
This is a single-center study with 170 infants, so results may not apply to all hospitals. The intervention is a dietary supplement, not a drug, so benefits may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NECROTIZING ENTEROCOLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Crouse Hospital
Syracuse, New York, 13210, United States